MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If
J. Clin. Invest. Barbara Schenk, et al. 108:1687 doi:10.1172/JCI13419 [Go to this article.]

Figure 1
(a) Isoelectric focusing of serum transferrin. Data from two different experiments are shown. The number of negative charges (sialic acid residues) is given at the left. Transferrin from healthy control individuals (lanes 1 and 5), from CDG-1a patients (lanes 2 and 7), from patient L (lane 3), patient A (lane 4), and patient S (lane 6) was analyzed. (b–d) Analysis of LLOs in CDG patients, control subjects, and yeast cells. Metabolically labeled LLOs were isolated from wild-type yeast cells (standard), ALG3-deficient yeast cells overexpressing the ALG6 locus (Δalg3 + pALG6), and fibroblasts derived from patient S (b), patient A (c), and patient L (d). [³H]oligosaccharides were released by mild acid hydrolysis and analyzed by HPLC. Elution was monitored by a radiodetector. The elution positions of Glc₃Man₉GlcNAc₂ (G₃M₉), Man₉GlcNAc₂ (M₉), Man₈GlcNAc₂ (M₈), Man₅GlcNAc₂ (M₅), and Glc₃Man₅GlcNAc₂ (G₃M₅) are indicated.